Selected research
Industry Research
Levosulpiride Industry Research Report 2026
Market perspective
The global Levosulpiride market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Levosulpiride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Levosulpiride is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Levosulpiride is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Levosulpiride include Sun Pharmaceutical Industries, Suzhou Chenghe Pharmaceutical & Chemical, Harbin Gloria Pharmaceuticals, Vasoya Industries, New Donghai Pharmaceutical and Bona Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Levosulpiride market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Levosulpiride Market by Company
Sun Pharmaceutical Industries
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Vasoya Industries
New Donghai Pharmaceutical
Bona Chemical
Levosulpiride Segment by Type
Above 98%
Below 98%
Levosulpiride Segment by Application
Tablet
Capsule
Other
Levosulpiride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Levosulpiride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Levosulpiride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Levosulpiride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Levosulpiride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Levosulpiride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Above 98%
- Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Sun Pharmaceutical Industries
- Suzhou Chenghe Pharmaceutical & Chemical
- Harbin Gloria Pharmaceuticals
- Vasoya Industries
- New Donghai Pharmaceutical
- Bona Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Levosulpiride Market Size (2021-2032)
- 2.2.2 Global Levosulpiride Sales (2021-2032)
- 2.2.3 Global Levosulpiride Market Average Price (2021-2032)
- 2.3 Levosulpiride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Above 98%
- 2.3.3 Below 98%
- 2.4 Levosulpiride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tablet
- 2.4.3 Capsule
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Levosulpiride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Levosulpiride Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Levosulpiride Revenue of Manufacturers (2021-2026)
- 3.4 Global Levosulpiride Average Price by Manufacturers (2021-2026)
- 3.5 Global Levosulpiride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Levosulpiride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Levosulpiride, Product Type & Application
- 3.8 Global Manufacturers of Levosulpiride, Established Date
- 3.9 Global Levosulpiride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries
- 4.1.1 Sun Pharmaceutical Industries Company Information
- 4.1.2 Sun Pharmaceutical Industries Business Overview
- 4.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Levosulpiride Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Recent Developments
- 4.2 Suzhou Chenghe Pharmaceutical & Chemical
- 4.2.1 Suzhou Chenghe Pharmaceutical & Chemical Company Information
- 4.2.2 Suzhou Chenghe Pharmaceutical & Chemical Business Overview
- 4.2.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Product Portfolio
- 4.2.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Developments
- 4.3 Harbin Gloria Pharmaceuticals
- 4.3.1 Harbin Gloria Pharmaceuticals Company Information
- 4.3.2 Harbin Gloria Pharmaceuticals Business Overview
- 4.3.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Harbin Gloria Pharmaceuticals Levosulpiride Product Portfolio
- 4.3.5 Harbin Gloria Pharmaceuticals Recent Developments
- 4.4 Vasoya Industries
- 4.4.1 Vasoya Industries Company Information
- 4.4.2 Vasoya Industries Business Overview
- 4.4.3 Vasoya Industries Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vasoya Industries Levosulpiride Product Portfolio
- 4.4.5 Vasoya Industries Recent Developments
- 4.5 New Donghai Pharmaceutical
- 4.5.1 New Donghai Pharmaceutical Company Information
- 4.5.2 New Donghai Pharmaceutical Business Overview
- 4.5.3 New Donghai Pharmaceutical Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 New Donghai Pharmaceutical Levosulpiride Product Portfolio
- 4.5.5 New Donghai Pharmaceutical Recent Developments
- 4.6 Bona Chemical
- 4.6.1 Bona Chemical Company Information
- 4.6.2 Bona Chemical Business Overview
- 4.6.3 Bona Chemical Levosulpiride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Bona Chemical Levosulpiride Product Portfolio
- 4.6.5 Bona Chemical Recent Developments
5 Global Levosulpiride Market Scenario by Region
- 5.1 Global Levosulpiride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Levosulpiride Sales by Region: 2021-2032
- 5.2.1 Global Levosulpiride Sales by Region: 2021-2026
- 5.2.2 Global Levosulpiride Sales by Region: 2027-2032
- 5.3 Global Levosulpiride Revenue by Region: 2021-2032
- 5.3.1 Global Levosulpiride Revenue by Region: 2021-2026
- 5.3.2 Global Levosulpiride Revenue by Region: 2027-2032
- 5.4 North America Levosulpiride Market Facts & Figures by Country
- 5.4.1 North America Levosulpiride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Levosulpiride Sales by Country (2021-2032)
- 5.4.3 North America Levosulpiride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Levosulpiride Market Facts & Figures by Country
- 5.5.1 Europe Levosulpiride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Levosulpiride Sales by Country (2021-2032)
- 5.5.3 Europe Levosulpiride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Levosulpiride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Levosulpiride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Levosulpiride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Levosulpiride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Levosulpiride Market Facts & Figures by Country
- 5.7.1 South America Levosulpiride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Levosulpiride Sales by Country (2021-2032)
- 5.7.3 South America Levosulpiride Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Levosulpiride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Levosulpiride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Levosulpiride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Levosulpiride Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Levosulpiride Sales by Type (2021-2032)
- 6.1.1 Global Levosulpiride Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Levosulpiride Sales Market Share by Type (2021-2032)
- 6.2 Global Levosulpiride Revenue by Type (2021-2032)
- 6.2.1 Global Levosulpiride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Levosulpiride Revenue Market Share by Type (2021-2032)
- 6.3 Global Levosulpiride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Levosulpiride Sales by Application (2021-2032)
- 7.1.1 Global Levosulpiride Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Levosulpiride Sales Market Share by Application (2021-2032)
- 7.2 Global Levosulpiride Revenue by Application (2021-2032)
- 7.2.1 Global Levosulpiride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Levosulpiride Revenue Market Share by Application (2021-2032)
- 7.3 Global Levosulpiride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Levosulpiride Value Chain Analysis
- 8.1.1 Levosulpiride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Levosulpiride Production Mode & Process
- 8.2 Levosulpiride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Levosulpiride Distributors
- 8.2.3 Levosulpiride Customers
9 Global Levosulpiride Analyzing Market Dynamics
- 9.1 Levosulpiride Industry Trends
- 9.2 Levosulpiride Industry Drivers
- 9.3 Levosulpiride Industry Opportunities and Challenges
- 9.4 Levosulpiride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst